tada - "PFE, MRK, JNJ, Astra Zenica, Bayer and many other mega pharmas all have products that they sell for many different ailments. Either yourself or Toinv has kept a list of all the ailments that APB has a positive effect on. If my memory is not to far gone that list is now in excess of 20. If any one of these companies was to buy us out and put APB on the market they would be canablizing sales of products in other divisions. This has nothing to do with what is best for scociety it's all about money."

I agree about the canabalization idea but not quite the implementation. If they commercialize Apabetalone, it could canabalize their existing drugs but at least the new revenues would come to them to replace some of the lost revenues. If they sit aside and let someone else bring it to market and it is that good, the other party's drug could take those same revenues away from their existing drugs and them get nothing while a competitior benefits. 

If they are really afraid of canabalization, they should be buying up all of the IP and not take it to market. Just shelve it or slowly develop it while they still collect the revenues from their existing drugs and bring it forward when it works for them. Apabetalone's lead might disappear while they wait but total control is in their hands to move when it works for them rather than a competitor taking away the revenues of their existing drugs.